Search results

Selected filters:

North America

Article type

Topic

Sector

Jurisdictions

23,831 results found for your search

Sort options
23 October 2019

IBM patent transaction puts Indian IT firm on par with rivals

Around 200 patents change hands as Big Blue selloff continues and a new HCL IP executive strikes first known deal

21 October 2019

If you think your insurance covers you for IP disputes, you may need to think again

Recent case law in the US shows that many companies who believed their insurers should pay-out on IP-related litigation claims have been left disappointed

19 October 2019

Why the Red Hat tail will end up wagging the Big Blue dog

IBM's decision to purchase the open source powerhouse was a $34 billion bet on the future and from an IP perspective something has to give

18 October 2019

Federal Circuit <em>Tarceva</em> decision is good news for oncology patent owners

Appellate court overturns PTAB invalidation, citing uncertainties of R&D in the lucrative cancer space, as well as lack of data in prior art

18 October 2019

AVANCI platform covers just under 50% of 3G and 4G SEPs, research for <em>IAM</em> indicates

The platform’s long list of licensors account for a significant chunk of technologies relating to connectivity, but LG Electronics and Huawei are major omissions

16 October 2019

Tencent dips back into patent market with third IBM deal

Chinese internet giant faces NPE litigation in the US and upstart Chinese rivals that are getting smart on patents

16 October 2019

WIPO report: US patent filings dip for first time since 2009

The number of grants also drops while UK sees worrying fall in applications; but study has good news for EPO President Campinos

15 October 2019

As PTAB settlement rate ticks up some see evidence of a maturing review system

Data shows both pre- and post-institution agreements at highest levels since 2014 and comes against backdrop of dramatic fall in new IPR filings

15 October 2019

California’s first-of-a-kind reverse payment law is a further obstacle to litigation settlements

Pharma patent litigation settlements involving the transfer of “anything of value” to the generic are now presumed anti-competitive under Golden State law

14 October 2019

A shift in focus at Microsoft sees part of its IP team head for the exit

Licensing specialists are understood to have been most affected in a round of departures which come a year after the company joined LOT Network and OIN

11 October 2019

Data reveals strong growth in the number of female inventors, but there is still a long way to go

A report by the UK IP Office finds more women named on patents than ever before – but also that they remain woefully under-represented. We present the top takeaways from a very timely study

11 October 2019

Patent litigation continues to fall in the US - but perhaps not all companies are noticing

While the number of new cases filed at district courts has declined through the year, analysis from RPX indicates that one key metric was up in the third quarter

10 October 2019

Suits against Facebook, Snap and Twitter indicated a Blackberry change of tack, but now it’s running into a familiar problem

PTAB IPR institutions pile up after the Canadian tech pioneer went on the patent offensive against giants of the social media market; how the cases pan out will be key to its licensing efforts

10 October 2019

Patent term adjustments in the US are readjusted, again

Two recent Federal Circuit decisions have shed further light on a highly litigated area of biopharma patent law

09 October 2019

Intel can’t knock out Chinese state lab’s chip patent

Invalidation efforts in both China and the United States have come up short as the US chip giant faces Chinese infringement claims